Bath & Body Works Inc has a consensus price target of $44.32, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, Piper Sandler, and Telsey Advisory Group on April 24, 2024, April 9, 2024, and April 5, 2024. With an average price target of $48.67 between Wells Fargo, Piper Sandler, and Telsey Advisory Group, there's an implied 4.95% upside for Bath & Body Works Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/24/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 3.52% | Wells Fargo | Ike Boruchow | $42 → $48 | Maintains | Equal-Weight | Get Alert |
04/09/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | -2.95% | Piper Sandler | Korinne Wolfmeyer | $44 → $45 | Maintains | Neutral | Get Alert |
04/05/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 14.3% | Telsey Advisory Group | Dana Telsey | $53 → $53 | Maintains | Outperform | Get Alert |
03/04/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 20.77% | Goldman Sachs | Kate McShane | $49 → $56 | Maintains | Buy | Get Alert |
03/04/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 12.14% | UBS | Jay Sole | $46 → $52 | Maintains | Neutral | Get Alert |
03/01/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | -9.42% | Wells Fargo | Ike Boruchow | $40 → $42 | Maintains | Equal-Weight | Get Alert |
03/01/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 16.45% | Baird | Mark Altschwager | $50 → $54 | Maintains | Outperform | Get Alert |
03/01/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 7.83% | BMO Capital | Simeon Siegel | $48 → $50 | Maintains | Outperform | Get Alert |
03/01/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 18.61% | TD Cowen | Gary Taylor | $35 → $55 | Maintains | Outperform | Get Alert |
03/01/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | -2.95% | Evercore ISI Group | Omar Saad | $30 → $45 | Maintains | In-Line | Get Alert |
03/01/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 14.3% | Telsey Advisory Group | Dana Telsey | $50 → $53 | Maintains | Outperform | Get Alert |
02/29/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 7.83% | Telsey Advisory Group | Dana Telsey | → $50 | Reiterates | Outperform → Outperform | Get Alert |
02/22/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | 7.83% | Telsey Advisory Group | Dana Telsey | → $50 | Reiterates | Outperform → Outperform | Get Alert |
02/14/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | -0.8% | UBS | Jay Sole | $44 → $46 | Maintains | Neutral | Get Alert |
01/04/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | -2.95% | Barclays | Adrienne Yih | $37 → $45 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/02/2024 | BBWI | Buy Now | Bath & Body Works | $46.37 | — | Goldman Sachs | Kate McShane | — | Maintains | Buy | Get Alert |
12/22/2023 | BBWI | Buy Now | Bath & Body Works | $46.37 | -13.74% | Wells Fargo | Ike Boruchow | $35 → $40 | Maintains | Equal-Weight | Get Alert |
11/17/2023 | BBWI | Buy Now | Bath & Body Works | $46.37 | -35.3% | Evercore ISI Group | Warren Cheng | $40 → $30 | Maintains | In-Line | Get Alert |
11/17/2023 | BBWI | Buy Now | Bath & Body Works | $46.37 | -9.42% | Telsey Advisory Group | Dana Telsey | $52 → $42 | Maintains | Outperform | Get Alert |
The latest price target for Bath & Body Works (NYSE: BBWI) was reported by Wells Fargo on April 24, 2024. The analyst firm set a price target for $48.00 expecting BBWI to rise to within 12 months (a possible 3.52% upside). 38 analyst firms have reported ratings in the last year.
The latest analyst rating for Bath & Body Works (NYSE: BBWI) was provided by Wells Fargo, and Bath & Body Works maintained their equal-weight rating.
The last upgrade for Bath & Body Works Inc happened on August 1, 2023 when Barclays raised their price target to $45. Barclays previously had an equal-weight for Bath & Body Works Inc.
The last downgrade for Bath & Body Works Inc happened on January 4, 2024 when Barclays changed their price target from $37 to $45 for Bath & Body Works Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bath & Body Works, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bath & Body Works was filed on April 24, 2024 so you should expect the next rating to be made available sometime around April 24, 2025.
While ratings are subjective and will change, the latest Bath & Body Works (BBWI) rating was a maintained with a price target of $42.00 to $48.00. The current price Bath & Body Works (BBWI) is trading at is $46.37, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.